Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs
Top Cited Papers
- 5 December 2007
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 370 (9604), 2054-2062
- https://doi.org/10.1016/s0140-6736(07)61699-7
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Preventive Polypill — Much Promise, Insufficient EvidenceNew England Journal of Medicine, 2007
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Medicine, 2006
- Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysisThe Lancet, 2006
- Preventing chronic diseases: how many lives can we save?The Lancet, 2005
- Can the world afford to save the lives of 6 million children each year?The Lancet, 2005
- Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settingsCochrane Database of Systematic Reviews, 2004
- Constraints to expanding access to health interventions: an empirical analysis and country typologyJournal of International Development, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Survival and cause of death after myocardial infarction: The Danish MONICA studyJournal of Clinical Epidemiology, 2001
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991